[{"indications": "Indications\u00a0adjunct to rehydration in acute diarrhoea\r\n(but see notes above); control of faecal consistency after colostomy\r\nor ileostomy (%s\n(From 1.8 Stoma care: British National Formulary)\n1.8 Stoma care)", "name": "CO-PHENOTROPE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.4 Acute diarrhoea", "1.4.2 Antimotility drugs", "CO-PHENOTROPE"], "cautions": "Cautions\u00a0section 4.7.2; also young children are particularly susceptible to overdosage and symptoms may be delayed and observation is needed for at least\r\n48 hours after ingestion; presence of subclinical\r\ndoses of atropine may give rise to atropine side-effects in susceptible\r\nindividuals or in overdosage (section 1.2); interactions: Appendix 1 (antimuscarinics, opioid analgesics)", "side-effects": "Side-effects\u00a0section 4.7.2 and\r\nalso see under Antimuscarinics (section 1.2); also\r\nabdominal pain, anorexia, and fever", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/201693.htm", "doses": ["See preparations", "initially 4 tablets, followed by 2 tablets every 6 hours\r\nuntil diarrhoea controlled; child under\r\n4 years see BNF for Children, 4\u20139 years 1 tablet 3 times daily, 9\u201312 years 1 tablet 4\r\ntimes daily, 12\u201316 years 2 tablets 3 times daily, but see also notes\r\nabove"], "pregnancy": "Pregnancy\u00a0section 4.7.2 and\r\nalso see under Atropine Sulphate (section 1.2)"}]